Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
SEIC
|
Dennis Mcgonigle
EVP, CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 20,000 Added 3.27% |
$477,200
$23.86 p/Share
|
Sep 28
2020 |
|
ODTC
|
Boxer Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 93,200 Added 1.8% |
$1,214,396
$13.03 p/Share
|
Sep 28
2020 |
|
BK
|
Emily Hope Portney
Sr. Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 3,427 Reduced 4.65% |
$117,512
$34.29 p/Share
|
Sep 28
2020 |
|
PGC
|
Gregory Martin Smith
SEVP, President Comml Banking |
SELL
Open market or private sale
|
Direct | 1,305 Reduced 41.85% |
$19,732
$15.12 p/Share
|
Sep 28
2020 |
|
FNF
|
Michael L Gravelle
Executive Vice President |
SELL
Open market or private sale
|
Direct | 58,000 Reduced 19.68% |
$1,846,720
$31.84 p/Share
|
Sep 28
2020 |
|
ORCC
|
Regents Of The University Of California |
SELL
Open market or private sale
|
Direct | 47,308 Reduced 0.11% |
$593,715
$12.55 p/Share
|
Sep 28
2020 |
|
CNO
|
Matthew J. Zimpfer
General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 1,676 Reduced 1.04% |
$27,269
$16.27 p/Share
|
Sep 28
2020 |
|
AMT
|
Robert D Hormats
Director |
SELL
Open market or private sale
|
Direct | 100 Reduced 1.62% |
$24,307
$243.07 p/Share
|
Sep 28
2020 |
|
NKE
|
Mark G Parker
EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct | 95,000 Reduced 6.26% |
$11,891,150
$125.17 p/Share
|
Sep 28
2020 |
|
NKE
|
Mark G Parker
EXECUTIVE CHAIRMAN |
BUY
Exercise of conversion of derivative security
|
Direct | 95,000 Added 5.89% |
$2,178,350
$22.93 p/Share
|
Sep 28
2020 |
|
NKE
|
Andrew Campion
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 80,000 Reduced 38.41% |
$10,046,400
$125.58 p/Share
|
Sep 28
2020 |
|
NKE
|
Andrew Campion
CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 80,000 Added 27.75% |
$3,100,800
$38.76 p/Share
|
Sep 28
2020 |
|
AVGO
|
Charlie B Kawwas
President, Semi Solutions Grp |
SELL
Open market or private sale
|
Direct | 6,142 Reduced 8.64% |
$2,227,273
$362.63 p/Share
|
Sep 28
2020 |
|
ARES
|
David B Kaplan
Co-Founder |
SELL
Open market or private sale
|
Indirect | 57,099 Reduced 5.92% |
$2,314,222
$40.53 p/Share
|
Sep 28
2020 |
|
ARES
|
Michael J Arougheti
Co-Founder and CEO |
SELL
Open market or private sale
|
Direct | 57,127 Reduced 7.81% |
$2,315,357
$40.53 p/Share
|
Sep 28
2020 |
|
CHK
|
Thomas L Ryan
Director |
SELL
Open market or private sale
|
Direct | 4,502 Reduced 100.0% |
$19,269
$4.28 p/Share
|
Sep 28
2020 |
|
CHK
|
Thomas L Ryan
Director |
SELL
Open market or private sale
|
Indirect | 900 Reduced 100.0% |
$3,852
$4.28 p/Share
|
Sep 28
2020 |
|
RCG
|
Murray Stahl
President/Co-Portfolio Manager |
BUY
Open market or private purchase
|
Indirect | 675 Added 0.56% |
$884
$1.31 p/Share
|
Sep 28
2020 |
|
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 14 Added 0.01% |
$6,461
$461.48 p/Share
|
Sep 28
2020 |
|
CNO
|
John R Kline
SVP and CAO |
SELL
Payment of exercise price or tax liability
|
Direct | 304 Reduced 0.35% |
$4,946
$16.27 p/Share
|
Sep 28
2020 |
|
HON
|
Darius Adamczyk
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 62,612 Reduced 31.2% |
$10,294,665
$164.42 p/Share
|
Sep 28
2020 |
|
HON
|
Darius Adamczyk
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 97,162 Added 32.62% |
$5,538,234
$57.0 p/Share
|
Sep 28
2020 |
|
HON
|
Darius Adamczyk
Director |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 14.49% |
$3,279,000
$163.95 p/Share
|
Sep 28
2020 |
|
COST
|
Susan L Decker
Director |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 10.31% |
$869,750
$347.9 p/Share
|
Sep 28
2020 |
|
WMT
|
Alice L Walton
> 10% Shareholder |
SELL
Bona fide gift
|
Direct | 1,525,000 Reduced 11.87% |
-
|
Sep 28
2020 |
|
FDX
|
R Brad Martin
Director |
SELL
Open market or private sale
|
Direct | 3,416 Reduced 6.21% |
$873,608
$255.74 p/Share
|
Sep 28
2020 |
|
FDX
|
R Brad Martin
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 5,970 Added 9.79% |
$410,557
$68.77 p/Share
|
Sep 28
2020 |
|
FDX
|
Jill Brannon
EVP - Chief Sales Officer |
SELL
Open market or private sale
|
Direct | 3,385 Reduced 38.05% |
$864,427
$255.37 p/Share
|
Sep 28
2020 |
|
FDX
|
Jill Brannon
EVP - Chief Sales Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 3,385 Added 27.56% |
$327,871
$96.86 p/Share
|
Sep 28
2020 |
|
FDX
|
Brie Carere
EVP/Chief Customer Officer |
SELL
Open market or private sale
|
Direct | 2,239 Reduced 16.32% |
$573,117
$255.97 p/Share
|
Sep 28
2020 |
|
FDX
|
Brie Carere
EVP/Chief Customer Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 2,239 Added 14.03% |
$269,128
$120.2 p/Share
|
Sep 28
2020 |
|
ACN
|
Jean Marc Ollagnier
CEO EMEA |
SELL
Open market or private sale
|
Direct | 450 Reduced 0.26% |
$99,702
$221.56 p/Share
|
Sep 28
2020 |
|
MRNA
|
Tal Zvi Zaks
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 17,197 Reduced 100.0% |
$1,207,229
$70.2 p/Share
|
Sep 28
2020 |
|
MRNA
|
Tal Zvi Zaks
Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 17,197 Added 50.0% |
$344,628
$20.04 p/Share
|
Sep 28
2020 |
|
FEIM
|
Edenbrook Capital, LLC
Director |
BUY
Open market or private purchase
|
Indirect | 2,988 Added 0.2% |
$30,776
$10.3 p/Share
|
Sep 28
2020 |
|
BKGM
|
Keven Felix Camacho
SVP/Chief Sales Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 204 Added 3.29% |
$1,620
$7.94 p/Share
|
Sep 28
2020 |
|
BKGM
|
Francisco M. Atalig
SVP/Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 256 Added 33.38% |
$2,033
$7.94 p/Share
|
Sep 28
2020 |
|
CRM
|
Marc Benioff
Chair and CEO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 0.05% |
$3,685,650
$245.71 p/Share
|
Sep 28
2020 |
|
CYTH
|
Armistice Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 0 Reduced 0.0% |
-
|
Sep 28
2020 |
|
CYTH
|
Armistice Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 4,966 Reduced 0.03% |
$646
$0.13 p/Share
|
Sep 28
2020 |
|
RCAT
|
Joseph P Hernon
CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 77,222 Added 50.0% |
$277,999
$3.6 p/Share
|
Sep 27
2020 |
|
EVRI
|
Michael D Rumbolz
Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 2,272 Reduced 0.59% |
$19,835
$8.73 p/Share
|
Sep 26
2020 |
|
EVRI
|
Michael D Rumbolz
Executive Chairman |
BUY
Exercise of conversion of derivative security
|
Direct | 5,776 Added 1.47% |
-
|
Sep 26
2020 |
|
NROM
|
William Wildman
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 11.11% |
$350
$0.35 p/Share
|
Sep 25
2020 |
|
BF-B
|
Augusta Brown Holland |
BUY
Bona fide gift
|
Direct | 5,066 Added 0.81% |
-
|
Sep 25
2020 |
|
CRSR
|
Randall J Weisenburger |
BUY
Open market or private purchase
|
Direct | 58,823 Added 46.23% |
$999,991
$17.0 p/Share
|
Sep 25
2020 |
|
CONN
|
Douglas H Martin
Director |
BUY
Bona fide gift
|
Indirect | 9,445 Added 7.3% |
-
|
Sep 25
2020 |
|
CONN
|
Douglas H Martin
Director |
SELL
Bona fide gift
|
Indirect | 9,445 Reduced 22.53% |
-
|
Sep 25
2020 |
|
CATC
|
Mark D Thompson |
SELL
Payment of exercise price or tax liability
|
Direct | 153 Reduced 2.36% |
$7,398
$48.35 p/Share
|
Sep 25
2020 |
|
TFFP
|
Glenn R. Mattes
President and CEO |
SELL
Open market or private sale
|
Indirect | 3,000 Reduced 30.0% |
$51,000
$17.0 p/Share
|
Sep 25
2020 |